Cytokinetics reported $-89445000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -113.06M 69.96M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Amgen AMGN:US $ 1476M 423M
Arca Biopharma ABIO:US $ -5.68M 1.58M
Bayer BAYN:GR € 3291M 2130M
Biogen BIIB:US $ 303.8M 64.4M
Brainstorm Cell Therapeutics BCLI:US $ -5.36M 0.83M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Capricor Therapeutics CAPR:US $ -7.82M 1.63M
Cytokinetics CYTK:US $ -89.44M 58.88M
Eisai 4523:JP Y -12403M 26575M
Eli Lilly And LLY:US $ 1902.9M 176.8M
Exelixis EXEL:US $ 68.57M 26.59M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Geron GERN:US $ -30.1M 1.92M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Intra Cellular Therapies ITCI:US $ -72.12M 13.62M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Merk MRK:US $ 4310M 552M
Novartis NOVN:VX SF 2222M 14086M
Pfizer PFE:US $ 7863M 4470M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M